Axsome Therapeutics (AXSM) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
Axsome Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 8 sold $134M of AXSM stock on the open market.
Get emailed when insiders cluster-buy stocks like AXSM
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
AXSM insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $24.6M | 4 |
| Q2 2026 | — | 0 | $26.8M | 13 |
| Q1 2026 | — | 0 | $43.3M | 8 |
| Q4 2025 | — | 0 | $45.1M | 11 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Axsome Therapeutics, Inc. insiders reported open-market purchases totaling $0, while 8 insiders reported sales totaling $134M. 36 of 36 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 3SEC | Mark L. JacobsonCOO | Sell Plan | 10,000 | $208.65 | $2.1M | -19.3% | — |
| Aug 7SEC | Herriot TabuteauCEO | Sell Plan | 45,0047,229 held (−86%) | $212.01 | $9.5M | -20.6% | — |
| Aug 7SEC | Herriot TabuteauCEO | Sell Plan | 4,6607,229 held (−39%) | $213.95 | $997K | -21.3% | — |
| Jul 1SEC | Herriot TabuteauCEO | Sell Plan | 49,6667,229 held (−87%) | $240.25 | $11.9M | -29.9% | — |
| Jun 11SEC | Roger JeffsDirector | Sell Plan | 28658,367 held (−0%) | $249.12 | $71K | -32.4% | — |
| Jun 11SEC | Roger JeffsDirector | Sell Plan | 28658,653 held (−0%) | $246.18 | $70K | -31.6% | — |
| Jun 10SEC | Mark ColemanDirector | Sell Plan | 64330,389 held (−2%) | $249.00 | $160K | -32.4% | — |
| Jun 10SEC | Susan MahonyDirector | Sell Plan | 300829 held (−27%) | $246.18 | $74K | -31.6% | — |
| Jun 10SEC | Susan MahonyDirector | Sell Plan | 3001,129 held (−21%) | $237.21 | $71K | -29.0% | — |
| Jun 9SEC | Herriot TabuteauCEO | Sell Plan | 49,6707,229 held (−87%) | $241.01 | $12.0M | -30.1% | — |
| Jun 9SEC | Nick PizzieCFO | Sell Plan | 33,00042,867 held (−43%) | $240.09 | $7.9M | -29.9% | — |
| Jun 2SEC | Mark ColemanDirector | Sell Plan | 6,00041,140 held (−13%) | $233.46 | $1.4M | -27.9% | — |
| Jun 2SEC | Mark ColemanDirector | Sell Plan | 6,00035,140 held (−15%) | $230.30 | $1.4M | -26.9% | — |
| Jun 2SEC | Mark ColemanDirector | Sell Plan | 5,53729,603 held (−16%) | $223.39 | $1.2M | -24.6% | — |
| May 5SEC | Mark L. JacobsonCOO | Sell Plan | 4,517 | $227.94 | $1.0M | -26.1% | — |
| May 5SEC | Mark L. JacobsonCOO | Sell Plan | 233 | $228.18 | $53K | -26.2% | — |
| Apr 23SEC | Ari MaizelChief Commercial Officer | Sell Plan | 7,500 | $182.42 | $1.4M | -7.7% | — |
| Feb 27SEC | Mark L. JacobsonCOO | Sell Plan | 35,378 | $161.88 | $5.7M | +4.0% | — |
| Feb 27SEC | Mark ColemanDirector | Sell Plan | 25,00047,140 held (−35%) | $161.11 | $4.0M | +4.5% | — |
| Feb 2SEC | Herriot TabuteauCEO | Sell Plan | 32,4107,229 held (−82%) | $185.60 | $6.0M | -9.3% | — |
| Jan 23SEC | Nick PizzieCFO | Sell Plan | 12,00042,588 held (−22%) | $187.92 | $2.3M | -10.4% | — |
| Jan 23SEC | Ari MaizelChief Commercial Officer | Sell Plan | 7,500 | $184.44 | $1.4M | -8.7% | — |
| Jan 7SEC | Herriot TabuteauCEO | Sell Plan | 78,7037,229 held (−92%) | $171.28 | $13.5M | -1.7% | — |
| Jan 7SEC | Herriot TabuteauCEO | Sell Plan | 31,2617,229 held (−81%) | $170.38 | $5.3M | -1.2% | — |
| Jan 7SEC | Herriot TabuteauCEO | Sell Plan | 29,4507,229 held (−80%) | $172.33 | $5.1M | -2.3% | — |
| Jan 2SEC | Mark E SaadDirector | Sell Plan | 31,34610,002 held (−76%) | $165.18 | $5.2M | +1.9% | — |
| Jan 2SEC | Mark E SaadDirector | Sell Plan | 6,23110,002 held (−38%) | $165.18 | $1.0M | +1.9% | — |
| Dec 4SEC | Herriot TabuteauCEO | Sell Plan | 49,2527,229 held (−87%) | $144.59 | $7.1M | +16.4% | — |
| Dec 4SEC | Herriot TabuteauCEO | Sell Plan | 20,1637,229 held (−74%) | $146.94 | $3.0M | +14.6% | — |
| Dec 4SEC | Herriot TabuteauCEO | Sell Plan | 10,5587,229 held (−59%) | $148.18 | $1.6M | +13.6% | — |
| Nov 5SEC | Herriot TabuteauCEO | Sell Plan | 91,7057,229 held (−93%) | $132.34 | $12.1M | +27.2% | — |
| Nov 5SEC | Herriot TabuteauCEO | Sell Plan | 50,4597,229 held (−87%) | $133.79 | $6.8M | +25.8% | — |
| Nov 5SEC | Herriot TabuteauCEO | Sell Plan | 21,7757,229 held (−75%) | $134.49 | $2.9M | +25.2% | — |
| Oct 8SEC | Herriot TabuteauCEO | Sell Plan | 19,2207,229 held (−73%) | $120.17 | $2.3M | +40.1% | — |
| Oct 8SEC | Herriot TabuteauCEO | Sell Plan | 13,3907,229 held (−65%) | $118.77 | $1.6M | +41.7% | — |
| Oct 8SEC | Herriot TabuteauCEO | Sell Plan | 12,7747,229 held (−64%) | $118.84 | $1.5M | +41.7% | — |
Insiders at Axsome Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Herriot TabuteauCEO | — | $103M | Aug 7, 2026 | — |
| Nick PizzieCFO | — | $10.2M | Jun 9, 2026 | — |
| Mark L. JacobsonCOO | — | $8.9M | Sep 3, 2026 | — |
| Mark ColemanDirector | — | $8.2M | Jun 10, 2026 | — |
| Mark E SaadDirector | — | $6.2M | Jan 2, 2026 | — |
| Ari MaizelChief Commercial Officer | — | $2.8M | Apr 23, 2026 | — |
| Susan MahonyDirector | — | $145K | Jun 10, 2026 | — |
| Roger JeffsDirector | — | $142K | Jun 11, 2026 | — |
AXSM stock: common questions
Are Axsome Therapeutics, Inc. insiders buying AXSM stock?
In the past 12 months, 0 insiders reported open-market purchases of AXSM worth $0.
Are Axsome Therapeutics, Inc. insiders selling AXSM stock?
8 insiders reported sales worth $134M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is AXSM's 52-week range?
Over the past year AXSM has traded between $121.15 and $255.17. It last closed at $168.35 on Oct 9, 2026.